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Abstract. 
 
Tight junctions (TJs) in endothelial cells are 
thought to determine vascular permeability. Recently, 
claudin-1 to -15 were identiﬁed as major components of 
TJ strands. Among these, claudin-5 (also called trans-
membrane protein deleted in velo-cardio-facial syn-
drome [TMVCF]) was expressed ubiquitously, even in 
organs lacking epithelial tissues, suggesting the possible 
involvement of this claudin species in endothelial TJs. 
We then obtained a claudin-6–speciﬁc polyclonal anti-
body and a polyclonal antibody that recognized both 
claudin-5/TMVCF and claudin-6. In the brain and lung, 
immunoﬂuorescence microscopy with these polyclonal 
antibodies showed that claudin-5/TMVCF was exclu-
sively concentrated at cell–cell borders of endothelial 
cells of all segments of blood vessels, but not at those of 
epithelial cells. Immunoreplica electron microscopy re-
vealed that claudin-5/TMVCF was a component of TJ 
strands. In contrast, in the kidney, the claudin-5/TM-
VCF signal was restricted to endothelial cells of arter-
ies, but was undetectable in those of veins and capillar-
ies. In addition, in all other tissues we examined, 
claudin-5/TMVCF was speciﬁcally detected in endothe-
lial cells of some segments of blood vessels, but not in 
epithelial cells. Furthermore, when claudin-5/TMVCF 
cDNA was introduced into mouse L ﬁbroblasts, TJ 
strands were reconstituted that resembled those in en-
dothelial cells in vivo, i.e., the extracellular face–associ-
 
ated TJs. These ﬁndings indicated that claudin-5/TMVCF 
is an endothelial cell–speciﬁc component of TJ strands.
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 cells provide a crucial interface be-
tween the blood and tissue environments. One of
the important functions of endothelial cells is to
determine and regulate vascular permeability, which is im-
portant not only in normal physiology to maintain the tis-
sue environment but also in pathological conditions such
as vasogenic edema and inflammation. Materials that are
transported across the endothelial sheets do so via two dis-
tinct pathways: transcellular and paracellular pathways
(for review see Spring, 1998).
Tight junctions (TJs)
 
1
 
 occur not only in endothelial cells
but also in simple epithelial cells. In these cells, TJs are
thought to be directly involved in barrier and fence func-
tions by sealing them to generate the primary barrier
against the diffusion of solutes through the paracellular
pathway and by acting as a boundary between the api-
cal and basolateral plasma membrane domains to create
and maintain cell polarity, respectively (for reviews see
Schneeberger and Lynch, 1992; Gumbiner, 1987, 1993;
Anderson and Van Itallie, 1995; Yap et al., 1998). On ul-
trathin section electron micrographs, TJs appear as a set of
discrete sites of apparent fusion involving the outer leaflet
of plasma membranes of adjacent cells (Farquhar and
Palade, 1963). On freeze–fracture electron micrographs
of most epithelial cells, TJs appear as a set of continu-
ous, anastomosing intramembranous particle strands (TJ
strands) in the protoplasmic face (P-face) with comple-
mentary grooves in the extracellular (E)-face (Staehelin,
1973, 1974).
The molecular architecture of TJs has been analyzed
mainly using simple epithelial cells. Several peripheral
membrane proteins such as ZO-1 (Stevenson et al., 1986),
ZO-2 (Gumbiner et al., 1991), ZO-3 (Balda et al., 1993;
Haskins et al., 1998), cingulin (Citi et al., 1988), 7H6 anti-
gen (Zhong et al., 1993), and symplekin (Keon et al., 1996)
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were shown to be concentrated at the cytoplasmic surface
of TJs. Occludin with four transmembrane domains was
the first TJ-specific integral membrane protein (Furuse et al.,
1993; Ando-Akatsuka et al., 1996). Occludin is thought to
be not only a structural component (Fujimoto, 1995; Fu-
ruse et al., 1996) but also a functional component of TJs;
occludin was shown to be directly involved in barrier func-
tions (McCarthy et al., 1996; Balda et al., 1996; Chen et al.,
1997; Wong and Gumbiner, 1997), in fence functions of
TJs (Balda et al., 1996), and in cell adhesion (Van Itallie
and Anderson, 1997).
Recently, the occludin gene was disrupted in embryonic
stem cells (Saitou et al., 1998). Unexpectedly, occludin-
deficient visceral endoderm cells that were differentiated
from occludin-knockout embryonic stem cells still bore a
well-developed network of TJ strands, pointing to the ex-
istence of as yet unidentified TJ-specific integral mem-
brane proteins. Recently, two novel integral membrane
proteins, claudin-1 and -2, were identified, which were lo-
calized exclusively in TJ strands (Furuse et al., 1998a).
Claudin-1 and -2 are structurally related (38% identical at
the amino acid [aa] sequence level) and appear to bear
four transmembrane domains, but show no sequence simi-
larity to occludin. Furthermore, when these claudin cDNAs
were singly introduced into L fibroblasts lacking TJs or
claudin expression, a huge network of TJ strands was in-
duced between stable transfectants (Furuse et al., 1998b).
These findings indicated that claudins are major structural
components of TJ strands (Tsukita and Furuse, 1999).
A database similarity search identified many claudin-
related sequences, and to date cDNAs encoding 13 more
claudin-like proteins have been isolated, which were desig-
nated as claudin-3 to -15 (Morita et al., 1999a,b; Tsukita
and Furuse, 1999). Northern blotting revealed that the tis-
sue expression pattern varied significantly between different
claudin species. Considering that endothelial cells express
the specific cadherin isoform, vascular endothelial–cadherin
(VE-cadherin) (Lampugnani et al., 1995), which shows
unique characteristics, the question has naturally arisen as
to whether there is an endothelial cell–specific claudin iso-
form. Claudin-5 (also called transmembrane protein de-
leted in velo-cardio-facial syndrome [TMVCF]) was sug-
gested to be a good candidate for such an endothelial
claudin, since it is expressed ubiquitously, even in organs
lacking epithelial tissues such as the brain, skeletal muscle,
and spleen (Morita et al., 1999a). In this study, we exam-
ined the expression and subcellular distribution of claudin-
5/TMVCF by immunofluorescence microscopy as well as
by immunoreplica electron microscopy, and found that
this claudin species is an endothelial cell–specific compo-
nent of TJ strands. We believe that this first description of
the endothelial claudin will allow development of new
methods with which to analyze the molecular mechanism
of the regulation of vascular permeability.
 
Materials and Methods
 
Antibodies and Cells
 
Rat antioccludin mAb (MOC37) was described previously (Saitou et al.,
1997). Anti–VE-cadherin mAb was a kind gift from Dr. N. Matsuyoshi
(Kyoto University, Kyoto, Japan). Anti–platelet endothelial cell adhesion
molecule (PECAM) polyclonal antibody (pAb) was purchased from
PharMingen. Mouse L cells and their transfectants were cultured in DME
supplemented with 10% FCS.
 
Production of pAbs
 
Two polypeptides, KYSAPRRPTANGDYDKKNYV and YSTSVPH-
SRGPSEYPTKNYV, which correspond to the COOH-terminal cytoplas-
mic domains of mouse claudin-5/TMVCF (aa 199–218) and claudin-6 (aa
200–219), respectively (a cysteine residue was added at their NH
 
2
 
 ter-
mini), were synthesized and coupled via the cysteine residue to keyhole
limpet hemocyanin. These peptides were injected into rabbits as antigens.
Rabbit antisera against the former and latter peptides were affinity-puri-
fied on nitrocellulose membranes with glutathione 
 
S
 
-transferase (GST)
fusion proteins with claudin-5/TMVCF and claudin-6
 
D
 
 to obtain anti–
claudin-5/6 pAb and anti–claudin-6 pAb, respectively (see Fig. 1 A).
 
Construction of Expression Vectors and Transfection
 
To construct claudin-5/TMVCF or claudin-6 expression vectors with or
without a FLAG-tag at their COOH termini, EcoRI sites were introduced
at 3
 
9
 
 ends of claudin cDNAs by PCR, and amplified fragments were sub-
cloned into pBluescript SK(
 
2
 
)–FLAG or SK(
 
2
 
). The inserts were ex-
cised by SaII-XbaI digestion followed by blunting with T4 polymerase,
and then introduced into pCAGGSneodelEcoRI (Niwa et al., 1991), pro-
vided by Dr. J. Miyazaki (Osaka University, Osaka, Japan).
Mouse L cells were used for transfection. Aliquots of 1 
 
m
 
g of each ex-
pression vector were introduced into L cells in 1 ml of DMEM using Lipo-
fectamine Plus (GIBCO BRL). After 24- or 48-h incubation, cells were re-
plated and cultured in DMEM containing 10% FCS and 500 
 
m
 
g/ml of
Geneticin (GIBCO BRL) to select stable transfectants.
 
Immunostaining
 
For whole-mount staining, mouse 12.5-d embryos were killed. Samples
were pretreated by microwaving in PBS for 20 s and fixed in 4%
paraformaldehyde/PBS for 30 min. They were dehydrated in methanol
and bleached with 30% H
 
2
 
O
 
2
 
. Samples were then rehydrated, blocked
with PBS-MT (0.2% Triton X-100 and 1% skimmed milk/PBS) and incu-
bated overnight with primary antibodies followed by secondary antibod-
ies. HRP-conjugated goat anti–rabbit Ig (Chemicon International, Inc.)
was used as a secondary antibody. They were then washed with PBS-MT
and PBS-T (0.2% Triton X-100/PBS), each for 5 h. Bound antibodies were
visualized by incubating with 0.025% diaminobenzidene, 0.08% NiCl
 
2
 
,
and 30% H
 
2
 
O
 
2 
 
in PBS-T.
Mouse brain, lung, kidney, and intestine were frozen using liquid nitro-
gen. Frozen sections 
 
z
 
6 
 
m
 
m thick were cut on a cryostat, mounted on
glass slides, air-dried, and fixed in 95% ethanol at 4
 
8
 
C for 30 min followed
by 100% acetone at room temperature for 1 min. They were then rinsed in
PBS containing 0.2% Triton X-100 for 15 min, blocked with 1% BSA/PBS
for 15 min, and incubated with primary antibodies. After washing with
PBS three times, samples were incubated for 30 min with secondary anti-
bodies. Cy3-conjugated goat anti–rat Ig (Amersham Pharmacia Biotech)
and Cy2-conjugated goat anti–rabbit Ig (Jackson ImmunoResearch Labo-
ratories, Inc.) were used as secondary antibodies. Samples were washed
three times with PBS, then mounted in 90% glycerol/PBS containing 0.1%
paraphenylenediamine and 1% 
 
n
 
-propylgalate. Specimens were observed
using a Zeiss Axiophot photomicroscope (Carl Zeiss, Inc.).
 
SDS-PAGE and Immunoblotting
 
Lysates of 
 
Escherichia coli
 
 expressing GST–claudin fusion proteins
(Morita et al., 1999a) were subjected to one-dimensional SDS-PAGE
(12.5%) according to the method of Laemmli (1970), and gels were
stained with Coomassie brilliant blue R-250. For immunoblotting, pro-
teins were electrophoretically transferred from gels onto nitrocellulose
membranes, which were then incubated with the first antibody. Bound
antibodies were detected with biotinylated secondary antibodies and
streptavidin-conjugated alkaline phosphatase (Amersham Pharmacia Bio-
tech). Nitroblue tetrazolium and bromochloroindolyl phosphate were
used as substrates for detection of alkaline phosphatase.
 
Freeze–Fracture Electron Microscopy
 
Immunoelectron microscopy to examine freeze–fracture replicas was
performed as described (Fujimoto, 1995). The mouse lung was cut into 
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small pieces and quickly frozen in high pressure liquid nitrogen with an
HPM 010 High Pressure Freezer (BAL-TEC). The frozen samples were
fractured at 
 
2
 
110
 
8
 
C and platinum-shadowed unidirectionally at an angle
of 45
 
8
 
 kin Balzers Freeze–Etch System (BAF 060; BAL-TEC). The sam-
ples were immersed in a sample lysis buffer containing 2.5% SDS, 10
mM Tris-HCl, and 0.6 M sucrose (pH 8.2) for 12 h at room temperature,
and then replicas floating off the samples were washed with PBS. Under
these conditions, integral membrane proteins were captured by replicas,
and their cytoplasmic domains were accessible to antibodies. The repli-
cas were incubated with anti–claudin-5/6 pAb for 60 min, then washed
with PBS several times. They were then incubated with goat anti–rabbit
Ig coupled to 10 nm gold (Amersham Pharmacia Biotech). The samples
were washed with PBS, picked up on formvar-filmed grids, and exam-
ined in a JEOL 1200EX electron microscope at an accelerating voltage
of 100 kV.
 
Results
 
Generation of Antibodies to Detect Claudin-5/TMVCF
 
The GST fusion protein with the cytoplasmic domain of
claudin-5/TMVCF (see Fig. 1 A) was produced in 
 
E. coli
 
and used as an antigen to generate specific pAbs in rab-
bits. Several pAbs that recognized claudin-5/TMVCF were
obtained, but all of them cross-reacted with claudin-6 on
immunoblotting (Fig. 1 B) as well as immunofluorescence
microscopy (Fig. 1 C). As shown in Fig. 1 A, the COOH-
terminal KNYV sequence was shared between claudin-5/
TMVCF and claudin-6. The GST fusion protein with the
cytoplasmic domain of claudin-6 lacking these four aa
(GST–claudin-6
 
D
 
) was not detected by these pAbs (Fig. 1
B), indicating that they specifically recognized the COOH-
terminal KNYV. These pAbs were then referred to as
anti–claudin-5/6 pAbs. On the other hand, when the GST
fusion protein with the cytoplasmic domain of claudin-6
was used as an antigen, several pAbs, which recognized
claudin-6 but not claudin-5/TMVCF on immunoblotting
(Fig. 1 B) as well as immunofluorescence microscopy (Fig.
1 C), were obtained (anti–claudin-6 pAb). As expected,
these pAbs recognized GST–claudin-6
 
D
 
 (Fig. 1 B). There-
fore, to examine the expression and localization of clau-
din-5/TMVCF in various tissues, these anti–claudin-5/6
pAbs and anti–claudin-6 pAbs were used in combination;
if some cells were anti–claudin-5/6 pAb-positive and anti–
claudin-6 pAb-negative, we concluded that they expressed
claudin-5/TMVCF. Fortunately, Northern blotting re-
vealed that in most organs of adult mice the expression of
claudin-6 was fairly restricted (Morita et al., 1999a).
 
Claudin-5/TMVCF in the Brain and Lung
 
We first examined the distribution of claudin-5/TMVCF in
the brain, which does not contain epithelial cells but ex-
pressed claudin-5/TMVCF as detected by Northern blot-
ting (Morita et al., 1999a). When 12.5-d mouse embryos
were labeled by whole-mount immunostaining with anti–
claudin-5/6 pAb, a characteristic tree-like staining pattern
was detected in the head portion (Fig. 2, a and b). Anti–
claudin-6 pAb gave no significant staining in the head por-
tion (Fig. 2 c), and a pAb specific for PECAM, a specific
marker for endothelial cells of blood vessels (Risau and
Flamme, 1995), showed a very similar staining pattern to
Figure 1. Specificity of pAbs.
(A) Amino acid sequences of
the cytoplasmic domains of
claudin-5/TMVCF and clau-
din-6. The COOH-terminal
KNYV is shared by these two
claudin species. Two poly-
peptides corresponding to
these sequences were used as
antigens to produce pAbs in
rabbits. (B) GST fusion pro-
teins with the cytoplasmic do-
mains of claudin-1 to -8 as
well as the cytoplasmic do-
main of claudin-6 lacking its
COOH-terminal KNYV (see
claudin-6D in A) were pro-
duced in E. coli. The lysates
of E. coli were separated by
SDS-PAGE (C.B.B. stain-
ing), followed by immuno-
blotting with two distinct
pAbs, which were raised
against the cytoplasmic do-
main of claudin-5/TMVCF or
claudin-6, respectively. The
former recognized both
GST–claudin-5/TMVCF and
GST–claudin-6, but not GST–claudin-6D, indicating that this pAb (referred to as anti–claudin-5/6 pAb) specifically bound to the
COOH-terminal KNYV sequence. The latter recognized GST–claudin-6 and GST–claudin-6D but not GST–claudin-5/TMVCF, indicat-
ing that this pAb (referred to as anti–claudin-6 pAb) was specific for the YSTSVPHSRGPSEYPT sequence of claudin-6 (see A). (C)
Anti–claudin-5/6 pAb immunofluorescently stained L transfectants expressing claudin-5/TMVCF (C5L cells) and claudin-6 (C6L cells),
whereas anti–claudin-6 pAb stained only C6L cells. Bar, 10 mm. 
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anti–claudin-5/6 pAb (Fig. 2 d). These findings indicated
that claudin-5/TMVCF was expressed exclusively in endo-
thelial cells of all segments of blood vessels in the fetal brain.
Frozen sections of adult brain were then immunofluo-
rescently double stained with anti–claudin-5/6 pAb and
anti–VE-cadherin mAb. VE-cadherin was reported to be
specifically expressed in endothelial cells (Lampugnani et
al., 1995). As shown in Fig. 2, e and f, all blood vessels
were exclusively costained with these antibodies. These
anti–VE-cadherin mAb-positive endothelial cells were
negative for staining with anti–claudin-6 pAb (Fig. 2, g and
h). Furthermore, at higher magnification, both claudin-5/
TMVCF and VE-cadherin were shown to be precisely co-
concentrated at cell–cell borders of endothelial cells of
blood vessels (Fig. 3). Taken all together, we concluded
that claudin-5/TMVCF is expressed and localized at cell–
cell contact sites of endothelial cells of all segments of
blood vessels in the adult brain.
Next, we examined the distribution of claudin-5/TM-
VCF in the lungs, which contained both epithelial and en-
dothelial cells and expressed fairly large amounts of clau-
din-5/TMVCF as detected by Northern blotting (Morita
et al., 1999a). When frozen sections of the lung were dou-
ble stained with anti–claudin-5/6 pAb and anti–VE-cad-
herin mAb, both signals completely overlapped (Fig. 4, a–
c). In contrast, on double staining with anti–claudin-5/6
pAb and antioccludin mAb, the two signals did not over-
lap at all (Fig. 4, d–f). Furthermore, anti–claudin-6 pAb
gave no detectable signals (data not shown). Considering
that occludin was expressed in epithelial cells but not in
most of the endothelial cells in nonneuronal tissues, these
findings indicated that claudin-5/TMVCF was expressed
in endothelial cells of all segments of blood vessels but
not in epithelial cells delineating the alveolar space in the
lung. Furthermore, immunoreplica analysis with anti–
claudin-5/6 pAb revealed that claudin-5/TMVCF was lo-
calized on the TJ strands of the endothelial cells of the
lung (Fig. 4 g).
Figure 2. Exclusive expression of
claudin-5/TMVCF in endothelial
cells in the brain. (a–d) Whole-
mount immunostaining. Mouse
12.5-d embryos were labeled with
anti–claudin-5/6 pAb (a and b),
anti–claudin-6 pAb (c), or anti-
PECAM pAb (d). Both anti–clau-
din-5/6 pAb and anti-PECAM pAb
showed similar tree-like staining of
blood vessels in the head portion.
In contrast, anti–claudin-6 pAb
yielded no signals in the head por-
tion. (e–h) Immunofluorescence
staining. Frozen sections of adult
mouse brain were double labeled
with anti–claudin-5/6 pAb (e) and
anti–VE-cadherin mAb (f) or anti–
claudin-6-pAb (g) and anti–VE-
cadherin mAb (h). Since anti–clau-
din-6 pAb yielded no signal at all,
anti–claudin-5/6 pAb staining can
be considered to represent the dis-
tribution of claudin–5/TMVCF. All
blood vessels in the brain were VE-
cadherin–positive, and claudin-5/
TMVCF was precisely colocalized
with VE-cadherin. Bars: 1 mm for
a, c, and d (d); 0.2 mm (b); 40 mm
for e–h (h). Cln, claudin; Cad, cad-
herin. 
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Figure 3. The precise colocalization of claudin-5/
TMVCF and VE-cadherin at the cell–cell borders of en-
dothelial cells in the brain. Blood vessels in frozen sec-
tions of adult mouse brain were double stained with anti–
claudin-5/6 pAb (a, green) and anti–VE-cadherin mAb
(b, red). Merged image (c) revealed that both staining
patterns precisely overlapped. Anti–claudin-6 pAb
yielded no signals (data not shown). Bar, 10 mm. Cln,
claudin; Cad, cadherin.
Figure 4. Localization of claudin-5/
TMVCF in the lung. (a–f) Frozen sec-
tions of the lung were double stained
with anti–claudin-5/6 pAb (a) and
anti–VE-cadherin mAb (b), or anti–
claudin-5/6 pAb (d) and antioccludin
mAb (e). Since anti–claudin-6 pAb
yielded no signals (data not shown),
the anti–claudin-5/6 pAb staining can
be considered to represent the distri-
bution of claudin-5/TMVCF. Merged
images (c and f) then revealed that
claudin-5/TMVCF was precisely colo-
calized with VE-cadherin and that the
claudin-5/TMVCF signals were com-
plementary to the occludin signals.
Considering that VE-cadherin and
occludin were expressed exclusively
in endothelial and epithelial cells, re-
spectively, in the lungs, these findings
indicated that the expression of clau-
din-5/TMVCF was restricted to en-
dothelial cells. (g) Freeze–fracture
replicas of the lung were labeled with
anti–claudin-5/6 pAb. Note the spe-
cific labeling on the TJ strands of en-
dothelial cells, which delineated the
capillary lumen (indicated by aster-
isks). RC, erythrocytes; Cln, claudin;
cad, cadherin. Bars: 20 mm in a–f (f);
100 nm (g). 
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Figure 5. Localization of claudin-5/TMVCF in the kidney and the intestine. Frozen sections of the kidney (a–h) and the intestine (i and
j) were double labeled with anti–claudin-5/6 pAb (a) and antioccludin mAb (b), anti–claudin-5/6 pAb (c) and anti–VE-cadherin mAb
(d), anti–claudin-6 pAb (e) and anti–VE-cadherin mAb (f), or anti–claudin-5/6 pAb (i) and antioccludin mAb (j). Since anti–claudin-6
pAb yielded no signals in the kidney (e) and the intestine (data not shown), the anti–claudin-5/6 pAb staining can be considered to rep-
resent the distribution of claudin-5/TMVCF. Claudin-5/TMVCF appeared to be expressed in a subset of blood vessels (arrows in a and
i) that were occludin-negative. Occludin was concentrated at TJs in distal tubules in the kidney (arrowheads in b) and intestinal epithe-
lial cells (arrowheads in j). In the kidney, VE-cadherin–positive intertubular capillaries (arrowheads in d and f) and glomerular capillar-
ies (asterisk in d and f) did not express claudin-5/TMVCF, but afferent and efferent arterioles (arrows in c and d) expressed both clau-
din-5/TMVCF and VE-cadherin. When transverse frozen sections of the thicker artery and vein (arrows and arrowheads, respectively,
in g and h) of the kidney were stained with anti–claudin-5/6 pAb, only the artery was intensely stained (g). (h) Phase–contrast image.
Bars: 40 mm for a–f (f); 70 mm in g and h (h); 40 mm in i and j (j). Cln, claudin; Cad, cadherin. 
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Claudin-5/TMVCF in the Kidney and Other Organs
 
In the kidney, claudin-5/TMVCF did not appear to be ex-
pressed in endothelial cells of all segments of the blood
vessels (Fig. 5). When frozen sections of the kidney cortex
were doubly-stained with anti–claudin-5/6 pAb and anti-
occludin mAb, some blood vessels running in the connec-
tive tissues surrounding renal tubules were stained with
anti–claudin-5/6 pAb but not with antioccludin mAb (Fig.
5, a and b). Instead, antioccludin mAb labeled TJs of distal
tubules intensely (Fig. 5 b). Anti–claudin-6 pAb showed
no significant signals (Fig. 5 e), indicating that only clau-
din-5/TMVCF was detected in the kidney by the anti–clau-
din-5/6 pAb. Judging from the density/number of the
claudin-5/TMVCF–positive blood vessels, only some se-
lected vessels appeared to be stained with anti–claudin-5/6
pAb. Frozen sections of the kidney were double stained
with anti–claudin-5/6 pAb and anti–VE-cadherin mAb
(Fig. 5, c and d). Anti–VE-cadherin mAb stained numer-
ous capillaries surrounding renal tubules and in glomeruli.
These intertubular and glomerular capillaries were not
stained by anti–claudin-5/6 pAb. Interestingly, afferent as
well as efferent arterioles of glomeruli were reproducibly
stained with anti–claudin-5/6 pAb (Fig. 5, c and d). Fur-
thermore, thicker arteries (probably interlobular arteries)
but not veins were also intensely stained with anti–clau-
din-5/6 pAb (Fig. 5, g and h). Taken together, we con-
cluded that in the kidney, claudin-5/TMVCF constituted
TJs only in endothelial cells of the arteries.
The expression and distribution of claudin-5/TMVCF
were also examined in other organs, among them the intes-
tine, skeletal muscle, skin, liver, testis. In these tissues clau-
din-5/TMVCF was specifically detected in endothelial cells
in some segments of blood vessels, but not in epithelial cells.
The endothelial cell–specific localization of claudin-5/TM-
VCF in the intestine was presented in Fig. 5, i and j.
 
Reconstitution of Extracellular Face–associated TJ 
Strands in L Fibroblasts by Claudin-5/TMVCF
 
We reported previously that claudin-1 and -2 reconstituted
TJ strands between adjacent transfectants when introduced
into L fibroblasts (Furuse et al., 1998b). Then, we exam-
ined the ability of claudin-5/TMVCF to reconstitute TJ
strands in L fibroblasts. When stable L transfectants ex-
pressing claudin-5/TMVCF were stained with anti–claudin-
5/6 pAb, claudin-5/TMVCF was shown to be concentrated
at cell–cell borders as planes, similar to claudin-1 and -2
(Fig. 6, a and b). Conventional freeze–fracture electron mi-
croscopy of glutaraldehyde-fixed L transfectants revealed
that huge well-developed networks of TJ strands were
formed in the cell–cell contact planes (Fig. 6 c). As shown
previously in L transfectants expressing claudin-1 and -2
(Furuse et al., 1998b), claudin-1–induced strands were
largely associated with the P-face as mostly continuous
structures with vacant grooves at the E-face (P-face–associ-
ated TJs), whereas claudin-2–induced strands were discon-
tinuous at the
 
 
 
P
 
-
 
face with complementary grooves at the
E-face that were occupied by chains of particles (E-face–
associated TJs). As shown in Fig. 6 c, the claudin-5/TMVCF–
induced TJs were an extreme case of the E-face–associated
TJs; almost all particles were associated with the E-face,
leaving particle-free ridges on the P-face (Fig. 6 c, insets).
 
Discussion
 
TJs are thought to be involved in the barrier and fence
functions in both epithelial and endothelial cells, but to
date no differences have been reported in the molecular
Figure 6. L transfectants expressing claudin-5/TMVCF. (a and b)
Immunofluorescence (a) and corresponding phase–contrast im-
ages (b) of stable L transfectants expressing claudin-5/TMVCF.
Cells were stained with anti–claudin-5/6 pAb. Expressed claudin-
5/TMVCF was concentrated at cell–cell borders as planes (ar-
rows). (c) Freeze–fracture images of cell–cell contact planes of
stable L transfectants expressing claudin-5/TMVCF. Well-devel-
oped TJ strand/groove networks were reconstituted. In these re-
constituted TJs, most TJ particles were recovered on the E-face;
in the E-face (E), the grooves were completely occupied by
chains of particles (arrow in upper inset), whereas only particle-
free ridges were observed on the P-face (P) (arrow in lower in-
set). Bars: 15 mm in a and b (b); 200 nm (c); 50 nm (insets). 
The Journal of Cell Biology, Volume 147, 1999 192
 
architecture of TJs between epithelial and endothelial
cells (Rubin, 1992; Schneeberger and Lynch, 1992; Bow-
man et al., 1992; Goodenough, 1999). In this study, we
found that claudin-5/TMVCF was expressed specifically in
endothelial cells, not in epithelial cells, and that this mole-
cule constituted TJ strands in endothelial cells. The human
TMVCF gene was originally found to be localized to chro-
mosome 22q11, which is frequently deleted in velo-cardio-
facial/DiGeorge syndrome patients (Sirotkin et al., 1997),
and we proposed to designate it as claudin-5/TMVCF
since it showed significant similarity to claudin-1 and -2
(Morita et al., 1999a). This gene was also identified as a
membrane protein named MBEC1 that was expressed in
the brain endothelial cells (Chen et al., 1998). In both stud-
ies, the concentration of the product of TMVCF/MBEC1
at TJs was not examined, probably due to the difficulty
generating antibodies specific for this protein. We avoided
this technical difficulty by generating and using anti–clau-
din-5/6 pAb and anti–claudin-6 pAb in combination. Im-
munofluorescence microscopy with these pAbs revealed
that in the brain and the lung, the endothelial cells of all
segments of blood vessels, which were positive in the anti–
VE-cadherin mAb staining, expressed significant amounts
of claudin-5/TMVCF. In contrast, in the kidney, veins and
capillaries lacked the expression of claudin-5/TMVCF,
and its expression was restricted to arteries. In addition,
in all other tissues we examined, the expression of claudin-
5/TMVCF was restricted to endothelial cells of some seg-
ments of blood vessels. Therefore, we concluded that clau-
din-5/TMVCF is an endothelial cell–specific component of
TJ strands, but that in contrast to VE-cadherin (Lampug-
nani et al., 1995), claudin-5/TMVCF is not expressed in all
types of endothelial cells.
Since it is widely accepted that TJs play central roles in
the regulation of vascular permeability, the structure of
endothelial TJs has been extensively examined, mainly by
freeze–fracture electron microscopy (Dempsey and Bulli-
vant, 1973; Simionescu et al., 1975, 1976; Schneeberger,
1982; Bowman et al., 1992). In general, in glutaraldehyde-
fixed endothelial cells in nonneuronal tissues, TJ strands in
endothelial cells were characterized by particle-free ridges
on the P-face and continuous grooves at the E-face, which
were densely occupied by chains of particles (E-face–asso-
ciated TJs) (Dempsey and Bullivant, 1973). Interestingly,
the claudin-5/TMVCF–based TJ strands reconstituted in L
transfectants showed the same morphological characteris-
tics (see Fig. 6), favoring the notion that claudin-5/TM-
VCF is a major constituent of endothelial TJ strands of
nonneuronal tissues in situ. Furthermore, in previous
freeze–fracture studies, TJs were shown to be developed
also in veins and capillaries in various tissues (Simionescu
et al., 1975, 1976; Schneeberger, 1982; Bowman et al.,
1992). Therefore, some species of claudins other than clau-
din-5/TMVCF must be involved in the formation of TJ
strands in veins and capillaries. To date, in addition to
pAbs used in this study, pAbs specific for claudin-2, -3, -4,
-8, -11, and -14 were available. Preliminary immunofluo-
rescence microscopy with these pAbs showed that these
claudins were not detected in endothelial cells in all of the
organs we examined. Among the other claudin species
(claudin-1, -7, -9, -10, -12, -13, and -15), claudin-1 is ex-
pected to be expressed in endothelial cells, since this clau-
 
din species is expressed rather ubiquitously, even in organs
lacking epithelial tissues as shown by Northern blotting
(Morita et al., 1999a). However, in contrast to claudin-5/
TMVCF, claudin-1 appeared to be expressed also in epi-
thelial cells, because this claudin species was first identi-
fied from hepatocytes and was expressed in large amounts
in the liver and the kidney (Furuse et al., 1998a). Further
identification and characterization of claudin species ex-
pressed in endothelial cells will be important in future studies.
Endothelial cells in the adult brain, which form the
blood–brain barrier (BBB), are coupled by TJs of ex-
tremely low permeability that are more like those of epi-
thelial barriers (Reese and Karnovsky, 1967; Brightman
and Reese, 1969; Risau and Wolburg, 1990; Rubin, 1992).
Despite the large numbers of in vivo studies that have
been performed, the developmental timing of the forma-
tion and maturation of BBB in vivo is still controversial,
but the TJs of brain endothelial cells are thought to be
leaky in embryos (Møllgård and Saunders, 1975; Farrell
and Risau, 1994). As shown in this study, claudin-5/TM-
VCF was clearly detected in endothelial cells of both the
fetal and adult brain (see Fig. 2), suggesting that the for-
mation and maturation of BBB is not attributable to the
developmental changes in the expression level of claudin-
5/TMVCF. TJ strands of endothelial cells in the fetal brain
are E-face–associated similarly to those in nonneuronal
tissues as discussed above, whereas those in the adult brain
are P-face–associated (Wolburg et al., 1994; Kniesel et al.,
1996). Therefore, it is tempting to speculate that during
development the claudin-5/TMVCF–based, E-face–associ-
ated TJ strands are modified by addition of other claudin
species or by some inside-out signaling, to be switched to
the P-face–associated forms.
Although occludin and claudins were identified as com-
ponents of epithelial TJ strands (Furuse et al., 1993; Ando-
Akatsuka et al., 1996; Furuse et al., 1998a; Morita et al.,
1999a), our knowledge of the molecular architecture of en-
dothelial TJs is limited. Occludin was reported to be ex-
pressed in large amounts in brain endothelial cells, but was
undetectable in most endothelial cells in nonneuronal tis-
sues (Saitou et al., 1997; Hirase et al., 1997). Now that clau-
din-5/TMVCF has been identified as a specific component
of endothelial TJ strands, it will be possible to examine
and modulate the mechanism of regulation of vascular
permeability in molecular terms. For example, vascular
endothelial cell growth factor has been shown to elevate
vascular permeability through binding to its tyrosine ki-
nase–type receptors flt-1 and flk-1 (Risau et al., 1998; Gale
and Yancopoulos, 1999), and to cause disorganization of
interendothelial junctions (Kevil et al., 1998). Thus, it
would be intriguing to examine whether and how activa-
tion of these receptors modulates claudin-5/TMVCF. Fur-
thermore, it will be important to analyze the possible in-
volvement of claudin-5/TMVCF in vasogenic edema and
inflammation in various pathological states. Further de-
tailed analyses of claudin-5/TMVCF along these lines will
lead to a better understanding of the molecular mecha-
nisms behind vascular permeability.
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Note Added in Proof. 
 
Positional cloning has identified a new member of
the claudin family (paracellin-1), mutations of which cause hereditary re-
nal hypomagnesemia in humans (Simon, D.B., Y. Lu, K.A. Choate, H.
Velazquez, E. Al-Sabban, M. Praga, G. Casari, A. Bettinelli, G. Colussi, J.
Rodriguez-Soriano, et al. 1999. Paracellin-1, a renal tight junction protein
required for paracellular Mg
 
2
 
1
 
 resorption. 
 
Science
 
. 285:103–106). This
new claudin species would be called claudin-16.
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